This study aims to investigate the association between oral vancomycin consumption and intestinal vancomycin-resistant Enterococcus carriage in the pre- and COVID era in the clinical center of the University of Szeged, Hungary. This retrospective microbiological examination was carried out using electronically collected data, corresponding to the period between 1 January 2018 and 31 December 2022, at the Department of Medical Microbiology. Data included isolated species and the according antimicrobial susceptibility patterns. Annual consumption data for oral vancomycin consumption were exported from the database of the Central Pharmacy of the Clinical Center. As a strain typing typing procedure, Fourier transform infrared spectroscopy analysis was used. There was a significant increase in the number of fecal vancomycin-resistant Enterococcus isolates throughout the study. The prevalence increased significantly during the years of the pandemic. The use of orally administered vancomycin in the clinical center increased significantly. A strong positive correlation existed between the two phenomena. Several strains with different resistance patterns spread in the clinical center. Two of these occurred in greater numbers, differing in their high-level aminoglycoside resistance. However, the overall resistance of these strains was stagnating. FTIR analysis revealed that 59 of the 62 strains were also divided into two large clusters differing partially in their high-level aminoglycoside resistance. During the pandemic, intestinal VRE carriage among clinical center patients increased significantly, linked to increased oral vancomycin use. Different strains spread, with aminoglycoside resistance being the primary distinction. This highlights the negative impact of the pandemic on VRE carriage.
No takes yet. Share an insight, caveat, or question.
László Orosz (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: